DYN logo

Dyne Therapeutics (DYN) Cash from investing

annual CFI:

-$204.08M-$287.39M(-344.96%)
December 31, 2024

Summary

  • As of today (May 29, 2025), DYN annual cash flow from investing activities is -$204.08 million, with the most recent change of -$287.39 million (-344.96%) on December 31, 2024.
  • During the last 3 years, DYN annual CFI has fallen by -$66.18 million (-48.00%).
  • DYN annual CFI is now -334.03% below its all-time high of $87.20 million, reached on December 31, 2022.

Performance

DYN Cash from investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherDYNcash flow metrics

quarterly CFI:

$1.46M+$17.47M(+109.11%)
March 31, 2025

Summary

  • As of today (May 29, 2025), DYN quarterly cash flow from investing activities is $1.46 million, with the most recent change of +$17.47 million (+109.11%) on March 31, 2025.
  • Over the past year, DYN quarterly CFI has increased by +$181.29 million (+100.81%).
  • DYN quarterly CFI is now -97.18% below its all-time high of $51.66 million, reached on September 30, 2022.

Performance

DYN quarterly CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherDYNcash flow metrics

TTM CFI:

-$22.78M+$181.29M(+88.84%)
March 31, 2025

Summary

  • As of today (May 29, 2025), DYN TTM cash flow from investing activities is -$22.78 million, with the most recent change of +$181.29 million (+88.84%) on March 31, 2025.
  • Over the past year, DYN TTM CFI has increased by +$100.81 million (+81.57%).
  • DYN TTM CFI is now -119.57% below its all-time high of $116.40 million, reached on March 31, 2023.

Performance

DYN TTM CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherDYNcash flow metrics

Cash from investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

DYN Cash from investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-345.0%+100.8%+81.6%
3 y3 years-48.0%+168.3%-95.5%
5 y5 years-10000.0%+791.0%-10000.0%

DYN Cash from investing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-334.0%at low-97.2%+100.8%-119.6%+88.8%
5 y5-year-334.0%at low-97.2%+100.8%-119.6%+88.8%
alltimeall time-334.0%at low-97.2%+100.8%-119.6%+88.8%

DYN Cash from investing History

DateAnnualQuarterlyTTM
Mar 2025
-
$1.46M(-109.1%)
-$22.78M(-88.8%)
Dec 2024
-$204.08M(-345.0%)
-$16.01M(-17.5%)
-$204.08M(+26.1%)
Sep 2024
-
-$19.40M(-273.6%)
-$161.87M(+24.9%)
Jun 2024
-
$11.17M(-106.2%)
-$129.65M(+4.9%)
Mar 2024
-
-$179.84M(-786.5%)
-$123.59M(-248.3%)
Dec 2023
$83.31M(-4.5%)
$26.20M(+104.3%)
$83.31M(+9.1%)
Sep 2023
-
$12.82M(-25.6%)
$76.35M(-33.7%)
Jun 2023
-
$17.23M(-36.3%)
$115.19M(-1.0%)
Mar 2023
-
$27.06M(+40.7%)
$116.40M(+33.5%)
Dec 2022
$87.20M
$19.24M(-62.8%)
$87.20M(+28.7%)
Sep 2022
-
$51.66M(+180.1%)
$67.73M(+412.2%)
DateAnnualQuarterlyTTM
Jun 2022
-
$18.44M(-963.4%)
$13.22M(-213.5%)
Mar 2022
-
-$2.14M(+808.9%)
-$11.65M(-91.5%)
Dec 2021
-$137.89M(+202.0%)
-$235.00K(-91.7%)
-$137.89M(-24.6%)
Sep 2021
-
-$2.85M(-55.7%)
-$182.88M(+1.5%)
Jun 2021
-
-$6.43M(-95.0%)
-$180.19M(+3.7%)
Mar 2021
-
-$128.38M(+183.9%)
-$173.82M(+280.7%)
Dec 2020
-$45.66M(+2672.4%)
-$45.22M(>+9900.0%)
-$45.66M(>+9900.0%)
Sep 2020
-
-$156.00K(+119.7%)
-$438.00K(+55.3%)
Jun 2020
-
-$71.00K(-66.4%)
-$282.00K(+33.6%)
Mar 2020
-
-$211.00K
-$211.00K
Dec 2019
-$1.65M(+1129.1%)
-
-
Dec 2018
-$134.00K
-
-

FAQ

  • What is Dyne Therapeutics annual cash flow from investing activities?
  • What is the all time high annual CFI for Dyne Therapeutics?
  • What is Dyne Therapeutics annual CFI year-on-year change?
  • What is Dyne Therapeutics quarterly cash flow from investing activities?
  • What is the all time high quarterly CFI for Dyne Therapeutics?
  • What is Dyne Therapeutics quarterly CFI year-on-year change?
  • What is Dyne Therapeutics TTM cash flow from investing activities?
  • What is the all time high TTM CFI for Dyne Therapeutics?
  • What is Dyne Therapeutics TTM CFI year-on-year change?

What is Dyne Therapeutics annual cash flow from investing activities?

The current annual CFI of DYN is -$204.08M

What is the all time high annual CFI for Dyne Therapeutics?

Dyne Therapeutics all-time high annual cash flow from investing activities is $87.20M

What is Dyne Therapeutics annual CFI year-on-year change?

Over the past year, DYN annual cash flow from investing activities has changed by -$287.39M (-344.96%)

What is Dyne Therapeutics quarterly cash flow from investing activities?

The current quarterly CFI of DYN is $1.46M

What is the all time high quarterly CFI for Dyne Therapeutics?

Dyne Therapeutics all-time high quarterly cash flow from investing activities is $51.66M

What is Dyne Therapeutics quarterly CFI year-on-year change?

Over the past year, DYN quarterly cash flow from investing activities has changed by +$181.29M (+100.81%)

What is Dyne Therapeutics TTM cash flow from investing activities?

The current TTM CFI of DYN is -$22.78M

What is the all time high TTM CFI for Dyne Therapeutics?

Dyne Therapeutics all-time high TTM cash flow from investing activities is $116.40M

What is Dyne Therapeutics TTM CFI year-on-year change?

Over the past year, DYN TTM cash flow from investing activities has changed by +$100.81M (+81.57%)
On this page